[Treatment of Behçet disease with levamisole].
作者信息
Hamza M, Ben Ayed H
出版信息
Tunis Med. 1979 Jan-Feb;57(1):17-9.
PMID:547458
Abstract
摘要
相似文献
1
[Treatment of Behçet disease with levamisole].
Tunis Med. 1979 Jan-Feb;57(1):17-9.
2
[Association of agramulocytosis caused by levamisole and HLA B27 in Behçet's disease].
Nouv Presse Med. 1979 Oct 15;8(39):3167-8.
3
The Adamantiadis-Behçet syndrome. Clinical and immunological observations.
Trans Ophthalmol Soc U K (1962). 1980;100(4):527-30.
4
Behcet's syndrome.
N Engl J Med. 1979 Aug 23;301(8):431-2. doi: 10.1056/NEJM197908233010811.
5
[The relationship of the HLA antigen system to Behçet's disease].
Vestn Dermatol Venerol. 1990(5):55-7.
6
The high prevalence of HLA-B5 in Behçet's disease.白塞病中HLA - B5的高患病率。
Clin Exp Immunol. 1977 Nov;30(2):259-61.
7
[The prevalence of HLA-B5 antigen in Behçet's disease].
Nouv Presse Med. 1978 Oct 21;7(36):3263.
8
[Clinical observations on 3 cases of Behçet's syndrome].
G Stomatol Ortognatodonzia. 1985 Oct-Dec;4(4):49-55.
9
High HL-A5 frequency in Behçet's disease.白塞病中HL-A5抗原频率较高。
Hokkaido Igaku Zasshi. 1976 Mar;51(2):117-21.
10
Current concepts of Behçet's disease.白塞病的当前概念。
Trans Ophthalmol Soc U K (1962). 1981;101 (Pt 4):422-8.
Zotero 插件